We are the combination of four hospitals: the General Hospital, the Children’s Hospital, the Women’s Hospital and the Traumatology, Rehabilitation and Burns Hospital. We are part of the Vall d’Hebron Barcelona Hospital Campus: a world-leading health park where healthcare plays a crucial role.
Patients are the centre and the core of our system. We are professionals committed to quality care and our organizational structure breaks down the traditional boundaries between departments and professional groups, with an exclusive model of knowledge areas.
Would you like to know what your stay at Vall d'Hebron will be like? Here you will find all the information.
The commitment of Vall d'Hebron University Hospital to innovation allows us to be at the forefront of medicine, providing first class care adapted to the changing needs of each patient.
The Clinical Trials Unit (UAC) within the Rheumatology Department was created in 2020 to provide support for clinical assays with medications that are backed by the pharmaceutical industry and research projects backed by investigators from the Rheumatology Department. Work is done in close collaboration with the USIC and other support units at Vall d'Hebron University Hospital (HUVH) and the Vall d'Hebron Research Institute (VHIR).
Clinical assays compare current treatments with others that may be better. They also allow us to offer new drugs and therapeutic options to patients for whom there are currently no treatment alternatives. Besides offering new pharmaceuticals, we are also participating in studies that evaluate innovative treatments, such as transcutaneous nerve stimulation for rheumatoid arthritis.
The patients seen at the Rheumatology Department of Vall d'Hebron University Hospital are considered potential candidates to participate in our clinical assays. Although not all of the patients will be eligible and some may not be interested in participating in a study, this option is given to everyone who meets the criteria for taking part under the different research protocols. The UAC provides support in trials, both for adult and paediatric patients with rheumatic diseases.
In addition, they collaboratively participate in other clinical trials that are spearheaded by other departments at Vall d'Hebron University Hospital.
Even though the unit was created just two years ago, the number of patients starting a new treatment as part of a clinical trial has increased in every research line conducted by the Rheumatology Department. In 2021, more than 40 clinical trials (phases II, III, and IV) and research projects were carried out.
Disorders associated with this Unit:
The acceptance of these terms implies that you give your consent to the processing of your personal data for the provision of the services you request through this portal and, if applicable, to carry out the necessary procedures with the administrations or public entities involved in the processing. You may exercise the mentioned rights by writing to web@vallhebron.cat, clearly indicating in the subject line “Exercise of LOPD rights”. Responsible entity: Vall d’Hebron University Hospital (Catalan Institute of Health). Purpose: Subscription to the Vall d’Hebron Barcelona Hospital Campus newsletter, where you will receive news, activities, and relevant information. Legal basis: Consent of the data subject. Data sharing: If applicable, with VHIR. No other data transfers are foreseen. No international transfer of personal data is foreseen. Rights: Access, rectification, deletion, and data portability, as well as restriction and objection to its processing. The user may revoke their consent at any time. Source: The data subject. Additional information: Additional information can be found at https://hospital.vallhebron.com/es/politica-de-proteccion-de-datos.